Table 3. Lymphocintigraphy parameters DUALN, VVAL, DBFL, CC and RAL as related to cumulative incidence of lymphedema by the end of follow-up.
| Lymphedema | Lymphedema | Lymphedema | Lymphedema | Lymphedema | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes (n = 15) | No (n = 48) | Yes (n = 15) | No (n = 48) | Yes (n = 15) | No (n = 48) | Yes (n = 15) | No (n = 48) | Yes (n = 15) | No (n = 48) | ||||||
| n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | ||||||
| DUALN | VVAL | DBFL | CC | RAL | |||||||||||
| Baseline | Intense | 4(15) | 22(85) | At 10 minute | 4 (15) | 23 (85) | Present | 0 | 0 | Present | 3(21) | 11(79) | Present | 5(21) | 19(79) |
| Moderate | 2(13) | 13(87) | After one hours | 5(21) | 19 (79) | Absent | 14(24) | 45(76) | Absent | 10(23) | 34(77) | Absent | 10(26) | 28(74) | |
| Mild | 4(25) | 12(75) | After two hour | 1 (17) | 5 (83) | P | <0.001 | P | 1 | p | 0.842 | ||||
| Absent | 5(100) | 0(0) | Not visualized | 5 (100) | 0(0) | ||||||||||
| p(Trend) | 0.003 | p(Trend) | 0.001 | ||||||||||||
| 2 months | Intense | 2(12) | 15(88) | At 10 minute | 3(19) | 13(81) | Present | 1(33) | 2(67) | Present | 1(8) | 12(92) | Present | 10(23) | 33(77) |
| Moderate | 1(8) | 12(92) | After one hours | 3(12.5) | 21(87.5) | Absent | 12(22) | 43(78) | Absent | 14(31) | 31(69) | Absent | 5(26) | 14(73) | |
| Mild | 9(39) | 14(61) | After two hour | 6(46) | 7(54) | P | 1 | P | 0.1806 | p | 1 | ||||
| Absent | 2(33) | 4(67) | Not visualized | 2(33) | 4(67) | ||||||||||
| p(Trend) | <0.001 | p(Trend) | 0.1115 | ||||||||||||
| 30 months | Intense | 0 (0) | 2(100) | At 10 minute | 0(0) | 2(100) | Present | 10(53) | 9(47) | Present | 6(22) | 21(78) | Present | 11(24) | 35(76) |
| Moderate | 6(37.5) | 15(62.5) | After one hours | 6(27) | 15(73) | Absent | 5(12) | 37(88) | Absent | 9(26.5) | 25(73.5) | Absent | 4(27) | 11(73) | |
| Mild | 5(33) | 10(67) | After two hour | 5(38.5) | 10(61.5) | ||||||||||
| Absent | 4(27) | 11(73) | Not visualized | 4(27) | 11(73) | p(Adjust) | 0.975 | p(Adjust) | 0.105 | p(Adjust) | 0.998 | ||||
| p(Trend) | <0.001 | p(Trend) | 0.1461 | ||||||||||||
DUALN = degree uptake in axillary lymph nodes; VVAL = velocity visualization of axillary lymph nodes; classified according to Table 1.11 The presence or absence of radiopharmaceutical absorption by the liver (RAL), collateral circulation (CC) and dermal backflow (DBFL) were also analyzed
All analyses were adjusted for age and BMI